IL139710A - Benzamide derivatives for the treatment of diseases mediated by cytokines - Google Patents
Benzamide derivatives for the treatment of diseases mediated by cytokinesInfo
- Publication number
- IL139710A IL139710A IL13971099A IL13971099A IL139710A IL 139710 A IL139710 A IL 139710A IL 13971099 A IL13971099 A IL 13971099A IL 13971099 A IL13971099 A IL 13971099A IL 139710 A IL139710 A IL 139710A
- Authority
- IL
- Israel
- Prior art keywords
- cytokines
- treatment
- diseases mediated
- benzamide derivatives
- 6alkoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/56—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/84—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9810356.7A GB9810356D0 (en) | 1998-05-15 | 1998-05-15 | Amide derivatives |
GBGB9905970.1A GB9905970D0 (en) | 1999-03-17 | 1999-03-17 | Amide derivatives |
PCT/GB1999/001491 WO1999059960A1 (en) | 1998-05-15 | 1999-05-11 | Benzamide derivatives for the treatment of diseases mediated by cytokines |
Publications (2)
Publication Number | Publication Date |
---|---|
IL139710A0 IL139710A0 (en) | 2002-02-10 |
IL139710A true IL139710A (en) | 2005-07-25 |
Family
ID=26313677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13971099A IL139710A (en) | 1998-05-15 | 1999-05-11 | Benzamide derivatives for the treatment of diseases mediated by cytokines |
Country Status (23)
Country | Link |
---|---|
US (1) | US6465455B1 (id) |
EP (1) | EP1077930B1 (id) |
JP (1) | JP2003505337A (id) |
KR (1) | KR100628284B1 (id) |
CN (1) | CN1188389C (id) |
AT (1) | ATE282023T1 (id) |
AU (1) | AU748397B2 (id) |
BR (1) | BR9910467A (id) |
CA (1) | CA2328699A1 (id) |
DE (1) | DE69921804T2 (id) |
ES (1) | ES2230853T3 (id) |
HK (1) | HK1033753A1 (id) |
HU (1) | HUP0102367A3 (id) |
ID (1) | ID27285A (id) |
IL (1) | IL139710A (id) |
NO (1) | NO20005766L (id) |
NZ (1) | NZ507143A (id) |
PL (1) | PL197181B1 (id) |
PT (1) | PT1077930E (id) |
RU (1) | RU2205823C2 (id) |
SK (1) | SK286247B6 (id) |
TR (1) | TR200003355T2 (id) |
WO (1) | WO1999059960A1 (id) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9816837D0 (en) | 1998-08-04 | 1998-09-30 | Zeneca Ltd | Amide derivatives |
US7772432B2 (en) | 1991-09-19 | 2010-08-10 | Astrazeneca Ab | Amidobenzamide derivatives which are useful as cytokine inhibitors |
IL134723A0 (en) | 1997-09-23 | 2001-04-30 | Zeneca Ltd | Amide derivatives for the treatment of diseases mediated by cytokines |
ES2232137T3 (es) | 1998-05-15 | 2005-05-16 | Astrazeneca Ab | Derivados de benzamida para el tratamiento de enfermedades mediadas por citoquinas. |
WO1999059960A1 (en) | 1998-05-15 | 1999-11-25 | Astrazeneca Ab | Benzamide derivatives for the treatment of diseases mediated by cytokines |
CN1142912C (zh) | 1998-08-04 | 2004-03-24 | 阿斯特拉曾尼卡有限公司 | 用作细胞因子产生的抑制剂的酰胺衍生物 |
CA2341370A1 (en) | 1998-08-20 | 2000-03-02 | Smithkline Beecham Corporation | Novel substituted triazole compounds |
KR100618074B1 (ko) | 1998-09-25 | 2006-08-30 | 아스트라제네카 아베 | 벤즈아미드 유도체 및 이것의 사이토킨 억제제로서 용도 |
PL350448A1 (en) * | 1999-03-17 | 2002-12-16 | Astrazeneca Ab | Amide derivatives |
ES2219319T3 (es) | 1999-03-17 | 2004-12-01 | Astrazeneca Ab | Derivados de amida. |
GB9906566D0 (en) | 1999-03-23 | 1999-05-19 | Zeneca Ltd | Chemical compounds |
GB9924092D0 (en) | 1999-10-13 | 1999-12-15 | Zeneca Ltd | Pyrimidine derivatives |
EP1235814B1 (en) | 1999-11-23 | 2004-11-03 | Smithkline Beecham Corporation | 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS |
US6943161B2 (en) | 1999-12-28 | 2005-09-13 | Pharmacopela Drug Discovery, Inc. | Pyrimidine and triazine kinase inhibitors |
CN101125138A (zh) * | 2000-12-18 | 2008-02-20 | 株式会社医药分子设计研究所 | 炎症性细胞因子产生游离抑制剂 |
WO2002068414A2 (en) | 2001-02-27 | 2002-09-06 | The Governement Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Analogs of thalidomide as potential angiogenesis inhibitors |
EP1535609A4 (en) * | 2002-06-10 | 2009-01-07 | Inst Med Molecular Design Inc | INHIBITOR OF NF-KB ACTIVATION |
AU2003281198A1 (en) * | 2002-07-04 | 2004-01-23 | Mitsui Chemicals, Inc. | m-PHENYLENEDIAMINE DERIVATIVE |
ATE349210T1 (de) | 2002-07-09 | 2007-01-15 | Boehringer Ingelheim Pharma | Pharazeutische zusammensetzungen aus anticholinergica und p38 kinase hemmern zur behandlung von erkrankungen der atemwege |
CA2808646C (en) | 2003-09-17 | 2016-08-23 | The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Thalidomide analogs as tnf-alpha modulators |
US8952895B2 (en) | 2011-06-03 | 2015-02-10 | Apple Inc. | Motion-based device operations |
GB0324790D0 (en) | 2003-10-24 | 2003-11-26 | Astrazeneca Ab | Amide derivatives |
US20060035893A1 (en) | 2004-08-07 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders |
PE20060777A1 (es) | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas |
EP1953148B1 (en) | 2005-10-28 | 2012-02-29 | Takeda Pharmaceutical Company Limited | Heterocyclic amide compound and use thereof |
DK1957461T3 (en) * | 2005-11-14 | 2016-12-19 | Genentech Inc | Bisamidhæmmere the hedgehog-signalling |
AU2007238785B2 (en) | 2006-04-13 | 2013-02-07 | Agnieszka Ambrozak | Tetrahalogenated compounds useful as inhibitors of angiogenesis |
US7671058B2 (en) * | 2006-06-21 | 2010-03-02 | Institute Of Medicinal Molecular Design, Inc. | N-(3,4-disubstituted phenyl) salicylamide derivatives |
WO2008089034A2 (en) * | 2007-01-11 | 2008-07-24 | Kemia, Inc. | Cytokine inhibitors |
EP1992344A1 (en) | 2007-05-18 | 2008-11-19 | Institut Curie | P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation |
US8927725B2 (en) | 2011-12-02 | 2015-01-06 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Thio compounds |
CN104326937B (zh) * | 2014-09-03 | 2016-08-24 | 天津市肿瘤研究所 | 抗肿瘤化合物及其医药用途 |
TWI808055B (zh) | 2016-05-11 | 2023-07-11 | 美商滬亞生物國際有限公司 | Hdac 抑制劑與 pd-1 抑制劑之組合治療 |
TWI794171B (zh) | 2016-05-11 | 2023-03-01 | 美商滬亞生物國際有限公司 | Hdac抑制劑與pd-l1抑制劑之組合治療 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1903899A (en) | 1933-04-18 | Cabboxylic acid abylides oe the benzene sebies and process oe making | ||
US1909960A (en) | 1929-08-06 | 1933-05-23 | Du Pont | Intermediate for azo dyes |
DE2812252A1 (de) | 1978-03-21 | 1979-10-04 | Bayer Ag | 1,2,4-triazol-blockierte polyisocyanate als vernetzer fuer lackbindemittel |
US4524168A (en) | 1981-11-18 | 1985-06-18 | Ciba-Geigy Corporation | Process for the mass coloration of polymers |
US4749729A (en) | 1984-06-21 | 1988-06-07 | American Cyanamid Company | Epoxy resin compositions curable above 160 F. and below 250 F. |
AU2552492A (en) | 1991-08-23 | 1993-03-16 | United States of America as represented by The Secretary Department of Health and Human Services, The | Raf protein kinase therapeutics |
GB9816837D0 (en) | 1998-08-04 | 1998-09-30 | Zeneca Ltd | Amide derivatives |
EP0871444A4 (en) | 1995-08-10 | 1999-01-13 | Merck & Co Inc | 2.5 SUBSTITUTED ARYL PYRROL, THE COMPOSITIONS THAT CONTAIN AND THE USE THEREOF |
KR100284382B1 (ko) * | 1995-08-22 | 2001-03-02 | 미즈노 마사루 | 아미드화합물 및 그의 용도 |
GB9604926D0 (en) | 1996-03-08 | 1996-05-08 | Sandoz Ltd | Organic compounds |
JP2001506230A (ja) * | 1996-08-09 | 2001-05-15 | スミスクライン・ビーチャム・コーポレイション | 新規ピペラジン含有化合物 |
GB9623833D0 (en) | 1996-11-16 | 1997-01-08 | Zeneca Ltd | Chemical compound |
IL134723A0 (en) * | 1997-09-23 | 2001-04-30 | Zeneca Ltd | Amide derivatives for the treatment of diseases mediated by cytokines |
GB9809347D0 (en) | 1998-05-05 | 1998-07-01 | Reckitt & Colmann Prod Ltd | Compositions |
ES2232137T3 (es) | 1998-05-15 | 2005-05-16 | Astrazeneca Ab | Derivados de benzamida para el tratamiento de enfermedades mediadas por citoquinas. |
WO1999059960A1 (en) | 1998-05-15 | 1999-11-25 | Astrazeneca Ab | Benzamide derivatives for the treatment of diseases mediated by cytokines |
CN1142912C (zh) | 1998-08-04 | 2004-03-24 | 阿斯特拉曾尼卡有限公司 | 用作细胞因子产生的抑制剂的酰胺衍生物 |
KR100618074B1 (ko) | 1998-09-25 | 2006-08-30 | 아스트라제네카 아베 | 벤즈아미드 유도체 및 이것의 사이토킨 억제제로서 용도 |
CN1158266C (zh) | 1998-10-01 | 2004-07-21 | 阿斯特拉曾尼卡有限公司 | 化合物 |
ES2219319T3 (es) | 1999-03-17 | 2004-12-01 | Astrazeneca Ab | Derivados de amida. |
PL350448A1 (en) | 1999-03-17 | 2002-12-16 | Astrazeneca Ab | Amide derivatives |
GB9924092D0 (en) | 1999-10-13 | 1999-12-15 | Zeneca Ltd | Pyrimidine derivatives |
-
1999
- 1999-05-11 WO PCT/GB1999/001491 patent/WO1999059960A1/en active IP Right Grant
- 1999-05-11 PL PL344185A patent/PL197181B1/pl not_active IP Right Cessation
- 1999-05-11 KR KR1020007012666A patent/KR100628284B1/ko not_active IP Right Cessation
- 1999-05-11 TR TR2000/03355T patent/TR200003355T2/xx unknown
- 1999-05-11 US US09/674,428 patent/US6465455B1/en not_active Expired - Fee Related
- 1999-05-11 CA CA002328699A patent/CA2328699A1/en not_active Abandoned
- 1999-05-11 DE DE69921804T patent/DE69921804T2/de not_active Expired - Fee Related
- 1999-05-11 BR BR9910467-9A patent/BR9910467A/pt not_active Application Discontinuation
- 1999-05-11 PT PT99921018T patent/PT1077930E/pt unknown
- 1999-05-11 RU RU2000131610/04A patent/RU2205823C2/ru not_active IP Right Cessation
- 1999-05-11 AT AT99921018T patent/ATE282023T1/de not_active IP Right Cessation
- 1999-05-11 HU HU0102367A patent/HUP0102367A3/hu unknown
- 1999-05-11 AU AU38392/99A patent/AU748397B2/en not_active Ceased
- 1999-05-11 NZ NZ507143A patent/NZ507143A/en unknown
- 1999-05-11 ES ES99921018T patent/ES2230853T3/es not_active Expired - Lifetime
- 1999-05-11 IL IL13971099A patent/IL139710A/xx not_active IP Right Cessation
- 1999-05-11 ID IDW20002240A patent/ID27285A/id unknown
- 1999-05-11 SK SK1717-2000A patent/SK286247B6/sk unknown
- 1999-05-11 EP EP99921018A patent/EP1077930B1/en not_active Expired - Lifetime
- 1999-05-11 CN CNB998061441A patent/CN1188389C/zh not_active Expired - Fee Related
- 1999-05-11 JP JP2000549579A patent/JP2003505337A/ja not_active Withdrawn
-
2000
- 2000-11-14 NO NO20005766A patent/NO20005766L/no unknown
-
2001
- 2001-06-20 HK HK01104299A patent/HK1033753A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ID27285A (id) | 2001-03-22 |
EP1077930A1 (en) | 2001-02-28 |
PL344185A1 (en) | 2001-10-08 |
DE69921804D1 (de) | 2004-12-16 |
KR100628284B1 (ko) | 2006-09-27 |
BR9910467A (pt) | 2001-01-09 |
HUP0102367A3 (en) | 2002-11-28 |
CA2328699A1 (en) | 1999-11-25 |
EP1077930B1 (en) | 2004-11-10 |
ES2230853T3 (es) | 2005-05-01 |
ATE282023T1 (de) | 2004-11-15 |
KR20010043547A (ko) | 2001-05-25 |
JP2003505337A (ja) | 2003-02-12 |
CN1188389C (zh) | 2005-02-09 |
US6465455B1 (en) | 2002-10-15 |
PT1077930E (pt) | 2005-03-31 |
NZ507143A (en) | 2003-08-29 |
TR200003355T2 (tr) | 2001-03-21 |
PL197181B1 (pl) | 2008-03-31 |
SK17172000A3 (sk) | 2001-04-09 |
DE69921804T2 (de) | 2005-10-27 |
IL139710A0 (en) | 2002-02-10 |
WO1999059960A1 (en) | 1999-11-25 |
AU748397B2 (en) | 2002-06-06 |
HUP0102367A2 (hu) | 2001-10-28 |
RU2205823C2 (ru) | 2003-06-10 |
CN1359371A (zh) | 2002-07-17 |
AU3839299A (en) | 1999-12-06 |
HK1033753A1 (en) | 2001-09-21 |
SK286247B6 (sk) | 2008-06-06 |
NO20005766L (no) | 2001-01-12 |
NO20005766D0 (no) | 2000-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1033753A1 (en) | Benzamide derivatives for the treatment of diseases mediated by cytokines. | |
DE69810134D1 (de) | Amide derivativen zur behandlung von durch cytokinen vermittelten krankheiten | |
ZA897660B (en) | Biologically active compounds | |
DE69209395D1 (de) | Therapeutische Amide | |
MY142177A (en) | Benzamide derivatives useful as histone deacetylase inhibitors | |
HUT46708A (en) | Process for producing heterocyclic ketones and pharmaceutical compositions containing them as active components | |
IL123002A0 (en) | 1-Phenyl-2- phenylacetoxy- ethanone derivatives | |
DE69531502D1 (de) | Monoamid, diamid, thiol enthaltende metall-chelatierende verbindungen | |
AP9701041A0 (en) | Pyridylpyrrole compounds. | |
GB9305295D0 (en) | Therapeutic compounds | |
IL111036A0 (en) | Beta_alanine derivatives, processes for the preparon thereof and pharmaceutical compositions containing the same | |
RU95105435A (ru) | N-замещенные производные 3-азабицикло [3.2.0]гептана в качестве нейролептического средства | |
GB9310095D0 (en) | Therapeutic compounds | |
NZ308398A (en) | 2-amino benzoxazin-4-one derivatives and medicaments | |
IL107315A0 (en) | 2-Saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and pharmaceutical compositions containing them | |
ES2095186A1 (es) | Derivados de epi-epibatidina. | |
DE3880304D1 (de) | 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung. | |
DK585986D0 (da) | Forbindelser beslaegtet med antibiotikum tan-749 og fremgangsmaade til fremstilling deraf | |
ATE212842T1 (de) | Quinoxalin-derivate zur behandlung von tinnitus | |
HUT47900A (en) | Process for producing new amides of butenic acid and pharmaceutical compositions containing them as active components |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
MM9K | Patent not in force due to non-payment of renewal fees |